Jon D. Hartman

406 total citations
8 papers, 348 citations indexed

About

Jon D. Hartman is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Jon D. Hartman has authored 8 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in Jon D. Hartman's work include Cancer therapeutics and mechanisms (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Computational Drug Discovery Methods (2 papers). Jon D. Hartman is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Computational Drug Discovery Methods (2 papers). Jon D. Hartman collaborates with scholars based in United States and United Kingdom. Jon D. Hartman's co-authors include Robert F. Bruns, Sheryl J. Hays, James H. Fergus, James A. Bristol, Che C. Huang, Edward W. Badger, Cheng Huang, Donald E. Butler, George Taylor and John H. Dodd and has published in prestigious journals such as Naunyn-Schmiedeberg s Archives of Pharmacology and Journal of Labelled Compounds and Radiopharmaceuticals.

In The Last Decade

Jon D. Hartman

8 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jon D. Hartman United States	4	263	192	145	43	42	8	348
Che C. Huang United States	3	262 1.0×	198 1.0×	150 1.0×	44 1.0×	45 1.1×	12	355
Edward W. Badger United States	5	377 1.4×	285 1.5×	180 1.2×	54 1.3×	104 2.5×	9	502
Thomas Friebe Germany	7	222 0.8×	195 1.0×	114 0.8×	80 1.9×	35 0.8×	8	419
Elizabeth Gizewski United States	16	426 1.6×	348 1.8×	123 0.8×	44 1.0×	59 1.4×	20	567
Daniela Tuscano Italy	13	308 1.2×	230 1.2×	92 0.6×	18 0.4×	102 2.4×	18	463
M Dóda Hungary	10	49 0.2×	158 0.8×	154 1.1×	71 1.7×	67 1.6×	39	377
Susanne Ahlberg Sweden	7	185 0.7×	161 0.8×	121 0.8×	57 1.3×	8 0.2×	9	361
Evan F. Williams United States	11	73 0.3×	129 0.7×	132 0.9×	34 0.8×	39 0.9×	23	342
J. J. F. Sarkis Brazil	9	231 0.9×	119 0.6×	119 0.8×	40 0.9×	9 0.2×	15	377
Cristina Zocchi Italy	14	626 2.4×	509 2.7×	166 1.1×	35 0.8×	220 5.2×	26	902

Countries citing papers authored by Jon D. Hartman

Since Specialization

Citations

This map shows the geographic impact of Jon D. Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon D. Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon D. Hartman more than expected).

Fields of papers citing papers by Jon D. Hartman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon D. Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon D. Hartman. The network helps show where Jon D. Hartman may publish in the future.

Co-authorship network of co-authors of Jon D. Hartman

This figure shows the co-authorship network connecting the top 25 collaborators of Jon D. Hartman. A scholar is included among the top collaborators of Jon D. Hartman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon D. Hartman. Jon D. Hartman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Woo, Peter W. K., Jon D. Hartman, Thomas N. Nanninga, et al.. (1999). Atorvastatin, an HMG-COA reductase inhibitor and efficient lipid-regulating agent. Part I. Synthesis of ring-labeled [14C6]atorvastatin. Journal of Labelled Compounds and Radiopharmaceuticals. 42(2). 121–127. 2 indexed citations

Woo, Peter W. K., Jon D. Hartman, J. Kevin Hicks, & Richard B. Hayes. (1999). Atorvastatin, an HMG-COA reductase inhibitor and effective lipid-regulating agent. Part III. Syntheses of [2H5]-, [13C8], and [13C7,15N]atorvastatin and their application in metabolic and pharmacokinetic studies. Journal of Labelled Compounds and Radiopharmaceuticals. 42(2). 135–145. 1 indexed citations

Hicks, James L., et al.. (1991). Synthesis of triple (¹³C₂, ¹⁵N), single (¹⁴C), and double (¹⁴C₂) labeled trimetrexate. Journal of Labelled Compounds and Radiopharmaceuticals. 29(4). 415–429. 1 indexed citations

Bruns, Robert F., James H. Fergus, Edward W. Badger, et al.. (1987). Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn-Schmiedeberg s Archives of Pharmacology. 335(1). 59–63. 329 indexed citations

Hartman, Jon D., et al.. (1986). Synthesis of [2‐¹⁴C]dezaguanine mesylate (6‐amino‐1,5‐dihydro‐4H‐imidazo[4,5‐c]pyridin‐4‐one‐6‐¹⁴C methanesulfonate), a new antitumor agent. Journal of Labelled Compounds and Radiopharmaceuticals. 23(1). 35–44. 1 indexed citations

Hartman, Jon D., John H. Dodd, James L. Hicks, et al.. (1985). Synthesis of ¹⁴C‐ and ³H‐labeled CI‐911 (dihydro‐1H‐pyrrolizine‐3, 5 (2H, 6H)‐dione). Journal of Labelled Compounds and Radiopharmaceuticals. 22(6). 583–594. 6 indexed citations

Hartman, Jon D., Cheng Huang, & Donald E. Butler. (1984). Synthesis of ¹⁴C‐labeled pramiracetam hydrochloride, N‐[2‐(bis[1‐methylethyl]amino)ethyl]‐2‐oxo‐1‐pyrrolidine‐acetamide‐α‐¹⁴C hydrochloride, CI‐879 hydrochloride. Journal of Labelled Compounds and Radiopharmaceuticals. 21(4). 347–352. 5 indexed citations

Putt, Sterling R., Jon D. Hartman, Hollis D. Showalter, John A. Kepler, & George Taylor. (1981). Synthesis of [8‐³H]Pentostatin. Journal of Labelled Compounds and Radiopharmaceuticals. 18(7). 925–931. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact